
Christopher Carlin, MB ChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.
Christopher Carlin, MB ChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.